Status:
COMPLETED
Heparin Binding Protein in Early Sepsis Diagnosis
Lead Sponsor:
Hellenic Institute for the Study of Sepsis
Collaborating Sponsors:
National and Kapodistrian University of Athens
Aristotle University Of Thessaloniki
Conditions:
Sepsis
Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary objective of this study is to use heparin-binding protein (HBP) concentration to indicate the presence, or outcome, of sepsis over 72 hours after ED admission. The secondary objectives of ...
Detailed Description
The purpose of this prospective, non-interventional, multi-centre clinical study is to assess the clinical validity of the Heparin Binding Protein (HBP) assay for indicating the presence, or outcome, ...
Eligibility Criteria
Inclusion
- Age ≥18 years
- Male or female
- Written informed consent
- Suspected infection
- Presence of at least ONE of the following:
- Temperature \> 38°C Temperature \< 36°C Heart rate \> 90 bpm Respiratory rate \> 20/min Self reported fever/chills
Exclusion
- None
Key Trial Info
Start Date :
September 22 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2018
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT03295825
Start Date
September 22 2017
End Date
September 30 2018
Last Update
October 23 2018
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Nafplion General Hospital
Nafplion, Argos, Greece, 21100
2
4th Department of Internal Medicine, ATTIKON University Hospital
Athens, Attica, Greece, 12462
3
Department of Internal Medicine, Chalkida General Hospital
Chalcis, Greece, 34100
4
Department of Internal Medicine, Siros General Hospital
Ermoupoli, Greece, 84100